Recursion alternatives and competitors
The closest alternatives to Recursion are Xaira Therapeutics, Insilico Medicine, Schrödinger and Eikon Therapeutics.
Recursion (Nasdaq: RXRX) is a Salt Lake City drug discovery company built around the Recursion OS, which pairs automated wet labs running up to 2 million experiments a week with machine learning foundation models trained on the resulting 50 petabyte plus dataset of cellular images…
10 alternatives to Recursion
What each product does, with its price as the vendor publishes it.
-
X
South San Francisco company founded in 2023 and launched publicly in April 2024 with more than $1 billion in committed funding, co led by ARCH Venture Partners and Foresite Labs.
Price: Not applicable
-
I
Insilico Medicine is a generative AI drug discovery company (HKEX: 3696), headquartered in Cambridge, Massachusetts with operations in Hong Kong, Abu Dhabi and Shanghai, that both licenses software and develops its own medicines.
Price: No published price
-
S
Computational chemistry software company (Nasdaq: SDGR) whose physics based molecular simulation platform is licensed to pharmaceutical, biotechnology, industrial and academic organizations, alongside a proprietary therapeutics pipeline built on the same platform.
Price: No published price
-
E
Drug discovery company built around super resolution live cell fluorescence microscopy, applying advanced optics descended from Nobel recognized single molecule imaging work together with machine learning to track how individual proteins behave and move inside living cells, rather than…
Price: Not applicable
-
P
PostEra is the medicinal chemistry counterpart to the biology platforms that dominate this category. Where Immunai, Cellarity and Enveda build models of cells, tissue or natural product chemistry to decide what to make, PostEra builds models of how to make it.
Price: No published price
-
D
Deep Genomics is a Toronto AI drug discovery company launched in 2015 by Brendan Frey out of his University of Toronto work on the genetic determinants of disease.
Price: No published price
-
N
Numerion Labs, formerly known as Atomwise, is a San Francisco AI drug discovery company developing small molecules for immune and inflammatory disease, led by chief executive Steve Worland.
Price: No published price
-
C
Chemify makes the molecules it designs, in a laboratory it built itself. Rather than handing a design to somebody with a laboratory, it is trying to turn its own laboratory into a printer.
Price: No published price
-
I
Iktos is a Paris generative AI and robotics company for small molecule drug discovery, founded in 2016.
Price: No published price
-
X
XtalPi is a drug and materials discovery company founded in Boston in 2015 by three MIT postdoctoral physicists, headquartered in Shenzhen and listed on the Hong Kong Stock Exchange (2228) since 2024.
Price: No published price
Recursion alternatives, answered
What are the best alternatives to Recursion?
The closest alternatives to Recursion are Xaira Therapeutics, Insilico Medicine, Schrödinger, Eikon Therapeutics and PostEra. Insilico Medicine is a generative AI drug discovery company (HKEX: 3696), headquartered in Cambridge, Massachusetts with operations in Hong Kong, Abu Dhabi and Shanghai, that both licenses software and develops its own medicines. PostEra is the medicinal chemistry counterpart to the biology platforms that dominate this category.
Who are Recursion's competitors?
Recursion's competitors in the Drug Discovery AI category include Xaira Therapeutics, Insilico Medicine, Schrödinger, Eikon Therapeutics, PostEra and Deep Genomics.